Platinum-based compounds can enter cancer cells by passive diffusion or CTR1-mediated import [47] and can be exported by ATPase copper-transporting alpha/beta (ATP7A/7B) and multidrug resistance-associated protein 2/4 (MRP2/4) [48,49]. This evidence concerns the gene ATP7A and cancer.